Aster DM Healthcare Q2 FY26 Earnings Call Transcript
Aster DM Healthcare reported a 10% YoY revenue increase to INR 1,197 Crore for Q2 FY26. Operating EBITDA rose by 13% YoY to INR 263 Crore. The…
Akzo Nobel India Limited JSW Paints’ Open Offer Closes with 70.20% Shareholding
JSW Paints Limited, along with PACs, has successfully completed its open offer for Akzo Nobel India Limited. Following the offer, JSW…
HLV Limited Q2 Financial Results, Leadership Changes Announced
HLV Limited announced its unaudited financial results for the second quarter ended September 30, 2025. The board approved the results and also…
HLV Limited Board Approves Unaudited Q2 Results, Appoints New Company Secretary
HLV Limited’s board has approved the unaudited financial results for Q2 (Jul-Sep) and the half-year ended September 30, 2025. The board…
NMDC Limited Board Declares No Interim Dividend for FY26
The Board of Directors of NMDC Limited has decided not to declare an interim dividend on the equity shares of the company for the fiscal year…
Natco Pharma Declares Interim Dividend of ₹1.50 Per Share
Natco Pharma has declared an interim dividend of ₹1.50 (Rupees One and paise fifty only) per equity share. This dividend, representing 75%, is…
Zydus Lifesciences Receives USFDA Approval for Leuprolide Acetate Injection
Zydus Lifesciences has received final approval from the USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial.…
NATCO Pharma Reports ₹1,463 Crore Revenue, Approves Interim Dividend
NATCO Pharma (NATCOPHARM) announced its Q2 FY26 results, reporting a consolidated total revenue of ₹1,463.0 Crore, up from ₹1,434.9 crore in…
Gujarat Mineral Development Corporation Reports Unaudited Financial Results for Q2 2026
Gujarat Mineral Development Corporation (GMDC) has announced its unaudited standalone and consolidated financial results for the quarter ended…
Natco Pharma Declares Interim Dividend of ₹1.50 Per Equity Share
Natco Pharma has declared an interim dividend of ₹1.50 (Rupees One and paise fifty only) per equity share of ₹2 each for the financial year…